Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Express Scripts
Dow
Moodys
McKesson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Mutual Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MUTUAL PHARM, and what generic and branded alternatives to MUTUAL PHARM drugs are available?

MUTUAL PHARM has fifty-four approved drugs.



Summary for Mutual Pharm
US Patents:0
Tradenames:24
Ingredients:23
NDAs:54
Patent Litigation for Mutual Pharm: See patent lawsuits for Mutual Pharm

Drugs and US Patents for Mutual Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mutual Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 089423-001 Feb 17, 1987 DISCN No No   Start Trial   Start Trial
Mutual Pharm CHLORTHALIDONE chlorthalidone TABLET;ORAL 089739-001 Sep 19, 1988 DISCN No No   Start Trial   Start Trial
Mutual Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 085742-002 May 11, 1982 DISCN No No   Start Trial   Start Trial
Mutual Pharm PREDNISONE prednisone TABLET;ORAL 080701-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Mutual Pharm HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088728-001 Apr 11, 1985 DISCN No No   Start Trial   Start Trial
Mutual Pharm HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 084107-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Mutual Pharm DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062418-001 Jan 28, 1983 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Medtronic
Baxter
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.